Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Phase III study of telisotuzumab vedotin (Teliso-V) vs docetaxel in pretreated c-Met overexpressing EGFR wildtype (WT) non-squamous (NSQ) locally advanced/ metastatic nonsmall cell lung cancer (a/mNSCLC)
- Authors
- Tanizaki, J.; Akamatsu, H.; Su, J.; Lee, G-W.; Xia, M. S.; Ainsworth, B.; Li, M.; Bolotin, E.; Seraj, J.; Lu, S.
- Issue Date
- Nov-2023
- Publisher
- Oxford University Press
- Citation
- Annals of Oncology, v.34, pp S1705 - S1706
- Indexed
- SCIE
SCOPUS
- Journal Title
- Annals of Oncology
- Volume
- 34
- Start Page
- S1705
- End Page
- S1706
- ISSN
- 0923-7534
1569-8041
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.